Search Within

Carol A Aghajanian

Formats
  1. Journal Article (325)
  2. Meeting Abstract (284)
  3. Review (3)
  4. Book Section (1)
  5. Correspondence (1)
  6. Editorial (1)
Groups
  1. Department of Medicine (615)
  2. GDMT, Medicine (615)
  3. Gynecologic Medicine Service (615)
  4. Gynecology Disease Management Team (615)
  5. Solid Tumor Oncology Division (615)
  6. Surgery (229)

More Groups

People
  1. Nadeem Abu-Rustum (126)
  2. Paul Sabbatini (125)
  3. Alexia Iasonos (116)
  4. David Spriggs (105)
  5. Roisin O'Cearbhaill (99)
  6. Martee Hensley (94)

More People

Years
  1. 2025 (24)
  2. 2024 (38)
  3. 2023 (42)
  4. 2022 (45)
  5. 2021 (35)
  6. 2020 (61)

More Years

Publications
  1. Gynecologic Oncology (200)
  2. Journal of Clinical Oncology (150)
  3. International Journal of Gynecological Cancer (57)
  4. Clinical Cancer Research (30)
  5. Annals of Oncology (28)
  6. Cancer (15)

More Publications

Publishers
  1. Elsevier B.V. (204)
  2. American Society of Clinical Oncology (156)
  3. Lippincott Williams & Wilkins (59)
  4. American Association for Cancer Research (54)
  5. Oxford University Press (30)
  6. Elsevier Inc. (21)

More Publishers

Results (615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Germline drivers of gynecologic carcinosarcoma
    Meeting Abstract

    Sia, T.; Birsoy, O.; Kemel, Y.; Maio, A.; Salo-Mullen, E.; Sheehan, M.; Hensley, M.; Rubinstein, M.; Makker, V.; Grisham, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomes
    Meeting Abstract

    Praiss, A.; Park, K.; Zhou, Q.; White, C.; Iasonos, A.; Zivanovic, O.; Abu-Rustum, N.; Weigelt, B.; Aghajanian, C.; Grisham, R.
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Pembrolizumab versus placebo in addition to carboplatin and paclitaxel for measurable stage 3 or 4a, stage 4b or recurrent endometrial cancer: The phase 3, NRG GY018 study
    Meeting Abstract

    Eskander, R.; Sill, M.; Beffa, L.; Moore, R.; Hope, J.; Musa, F.; Mannel, R.; Shahin, M.; Cantuaria, G.; Girda, E.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Evolution of peripheral and tumor immune parameters as biomarkers of differential sequencing of immune checkpoint blockade and chemoradiotherapy in locally advanced cervical cancer: An NRG Oncology/GOG Study
    Meeting Abstract

    Zamarin, D.; Deng, W.; Lankes, H.; Ghamande, S.; Holman, L.; Mathews, C.; Park, K.; Banbury, B.; Sherry, N.; Kim, H.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Transforming ovarian cancer care by targeting minimal residual disease
    Editorial

    Jazaeri, A. A.; Grisham, R.; Knisely, A.; Spranger, S.; Zamarin, D.; Hillman, R. T.; Lawson, B. C.; Burns, K. H.; Lee, S.; Westin, S. N.; more...
    Med (2023)

    Fulltext@MSK | Save
  • Assessing the genomic landscape of cervical cancers: Clinical opportunities and therapeutic targets
    Journal Article

    Friedman, C. F.; Ravichandran, V.; Miller, K.; Vanderbilt, C.; Zhou, Q.; Iasonos, A.; Vivek, M.; Mishra, P.; Leitao, M. M. Jr; Broach, V.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Molecular results and potential biomarkers identified from the phase 3 MILO/ENGOT-ov11 study of binimetinib versus physician choice of chemotherapy in recurrent low-grade serous ovarian cancer
    Journal Article

    Grisham, R. N.; Vergote, I.; Banerjee, S.; Drill, E.; Kalbacher, E.; Mirza, M. R.; Romero, I.; Vuylsteke, P.; Coleman, R. L.; Hilpert, F.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Molecular characterization of endometrial carcinomas in black and white patients reveals disparate drivers with therapeutic implications
    Journal Article

    Weigelt, B.; Marra, A.; Selenica, P.; Rios-Doria, E.; Momeni-Boroujeni, A.; Berger, M. F.; Arora, K.; Nemirovsky, D.; Iasonos, A.; Chakravarty, D.; more...
    Cancer Discovery (2023)

    Fulltext@MSK | Save
  • TERT promoter mutations and gene amplification in endometrial cancer
    Journal Article

    Praiss, A. M.; Marra, A.; Zhou, Q.; Rios-Doria, E.; Momeni-Boroujeni, A.; Iasonos, A.; Selenica, P.; Brown, D. N.; Aghajanian, C.; Abu-Rustum, N. R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Pembrolizumab plus chemotherapy in advanced endometrial cancer
    Journal Article

    Eskander, R. N.; Sill, M. W.; Beffa, L.; Moore, R. G.; Hope, J. M.; Musa, F. B.; Mannel, R.; Shahin, M. S.; Cantuaria, G. H.; Girda, E.; more...
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save